medbridgehealthcare.com

What It Is

MedBridge Healthcare is a U.S.-based sleep medicine management service provider. It serves hospitals, health systems, physician practices, insurers, ACOs, and individual patients, offering sleep lab management, home sleep apnea testing (HSAT), therapy coordination, and hospital readmission reduction programs. The website emphasizes its “dynamic software platform,” which connects patient information across the journey from diagnosis to treatment. However, based on publicly available content, it appears to be more of a “medical operations services + software platform” combination rather than a pure SaaS product.

Core Capabilities

Its core modules include outsourced or on-demand sleep lab services, mail-to-home HSAT programs, screening/diagnosis/consultation/treatment pathways, PAP therapy-related Outcome & Compliance reporting, and readmission reduction programs for high-risk patients with conditions such as CHF and COPD. The readmission program includes bedside enrollment, patient education, telemedicine and real-time collaboration, evidence-based clinical protocols, remote monitoring, daily check-ins, medication coordination, and ongoing post-discharge support. The website also mentions the ability to integrate metrics such as heart rate, blood pressure, and sleep patterns via device APIs, as well as partnerships with American TelePhysicians, collaboratehealth, Onera, and others.

Pricing and Business Model

Public pages do not list packages, unit pricing, or subscription tiers. Hospital-side customers need to schedule a demo or contact sales. Patients can directly order home sleep testing, but the scraped text does not show pricing. The readmission reduction program states that hospitals can use it with “no financial risk,” but it does not clarify whether the model is outcome-based payment, insurance reimbursement, or something else.

Pros and Cons

Its strengths lie in its complete service chain, covering screening, testing, diagnosis, therapy coordination, and follow-up. It is also positioned around partnerships with healthcare institutions, emphasizing clinical outcomes, cost control, and operational efficiency. Its sleep diagnostic centers across multiple U.S. locations perform more than 70,000 diagnostic procedures annually, indicating a certain level of offline service capability. The downside is limited disclosure around the enterprise software itself: there is a lack of product interface previews, workflow details, permission structures, API documentation, data security information, and deployment model explanations. Pricing is also not transparent.

Who It’s For and Access from China

It is better suited to U.S. hospitals, health systems, clinics, or organizations that need to outsource sleep programs, as well as U.S. patients seeking home sleep apnea testing. For Chinese medical institutions, there are uncertainties around compliance, telemedicine practice requirements, device delivery, and integration with local medical insurance and EMR systems. The text does not provide information on access from China, so its availability is unknown.